Plain-English translation of NCT02852928 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a European research effort that brings together information about children with rare interstitial lung diseases — conditions that affect the deep parts of the lungs and make it hard to breathe. Researchers are creating a shared database and biobank (a collection of blood and tissue samples) so that doctors across Europe can learn from each child's case, improve how they diagnose these diseases, and develop better treatment plans.
Children with rare lung diseases often go years without a clear diagnosis because these conditions are so uncommon and hard to identify. By collecting information from many children across Europe in one place, doctors hope to recognize patterns, standardize the best ways to diagnose and follow these patients, and ultimately find more effective treatments.
You likely qualify if…
You likely don't qualify if…
Your participation involves sharing your medical information (like test results and imaging scans you've already had or will have as part of your normal care) and allowing researchers to collect small biological samples (such as blood) that will be stored in a biobank for research. You will likely have regular follow-up visits with your doctor as part of the study, and researchers will monitor how your condition changes over time and how different treatments work for you. The study aims to follow children across Europe, so the length of participation may vary depending on your individual situation.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Germany
Turkey (Türkiye)
United Kingdom